Terms: = Head and neck cancer AND NOTCH1, TAN1, P46531, 4851, ENSG00000148400, hN1
412 results:
1. Inhibition of SUV39H1 reduces tumor angiogenesis via notch1 in oral squamous cell carcinoma.
Chen Y; Weng X; Zhang C; Wang S; Wu X; Cheng B
PeerJ; 2024; 12():e17222. PubMed ID: 38650654
[TBL] [Abstract] [Full Text] [Related]
2. Therapeutic Advances and Challenges for the Management of HPV-Associated Oropharyngeal cancer.
Muniz IAF; Araujo M; Bouassaly J; Farshadi F; Atique M; Esfahani K; Bonan PRF; Hier M; Mascarella M; Mlynarek A; Alaoui-Jamali M; Silva SDD
Int J Mol Sci; 2024 Apr; 25(7):. PubMed ID: 38612819
[TBL] [Abstract] [Full Text] [Related]
3. Notch signaling genes and CD8
Ogi K; Iwamoto T; Sasaya T; Nishiyama K; Tokura T; Sasaki T; Dehari H; Arihara Y; Murase K; Saito M; Someya M; Takada K; Miyazaki A
Cancer Med; 2024 Mar; 13(5):e6985. PubMed ID: 38491819
[TBL] [Abstract] [Full Text] [Related]
4. An update of clinical value of circulating tumor DNA in esophageal cancer: a systematic review and meta-analysis.
Zhang Y; Du H; Wang N; Wang L; Huang Y
BMC Cancer; 2024 Jan; 24(1):129. PubMed ID: 38267901
[TBL] [Abstract] [Full Text] [Related]
5. Anti-notch1 therapy with OMP-52 M51 inhibits salivary adenoid cystic carcinoma by depressing epithelial-mesenchymal transition (EMT) process and inducing ferroptosis.
Li R; Hu Z; Qiao Q; Zhou D; Sun M
Toxicol Appl Pharmacol; 2024 Mar; 484():116825. PubMed ID: 38253083
[TBL] [Abstract] [Full Text] [Related]
6. PRT543, a protein arginine methyltransferase 5 inhibitor, in patients with advanced adenoid cystic carcinoma: An open-label, phase I dose-expansion study.
Ferrarotto R; Swiecicki PL; Zandberg DP; Baiocchi RA; Wesolowski R; Rodriguez CP; McKean M; Kang H; Monga V; Nath R; Palmisiano N; Babbar N; Sun W; Hanna GJ
Oral Oncol; 2024 Feb; 149():106634. PubMed ID: 38118249
[TBL] [Abstract] [Full Text] [Related]
7. Chaperonin containing TCP1 subunit 6A may activate Notch and Wnt pathways to facilitate the malignant behaviors and cancer stemness in oral squamous cell carcinoma.
Chen Y; Chen Y; Liu W
Cancer Biol Ther; 2024 Dec; 25(1):2287122. PubMed ID: 38084868
[TBL] [Abstract] [Full Text] [Related]
8. Epigenetic inhibition of CTCF by hn1 promotes dedifferentiation and stemness of anaplastic thyroid cancer.
Pan Z; Lu X; Xu T; Chen J; Bao L; Li Y; Gong Y; Che Y; Zou X; Tan Z; Huang P; Ge M
Cancer Lett; 2024 Jan; 580():216496. PubMed ID: 37993084
[TBL] [Abstract] [Full Text] [Related]
9. Whole exome sequencing uncovers HRAS mutations as potential mediators of resistance to metronomic chemotherapy.
Sambath J; Noronha V; Manda SS; Mishra R; Chandrani P; Patil V; Menon N; Chougule A; Ramachandran V; Limaye S; Kuriakose MA; Banavali SD; Kumar P; Prabhash K
Gene; 2024 Jan; 893():147952. PubMed ID: 37918550
[TBL] [Abstract] [Full Text] [Related]
10. Single-cell sequencing reveals SATB2/notch1 signaling promotes the progression of malignancy of epithelial cells from papillary thyroid cancer.
Zhang W; Wang J; Huang D; Liu Z; Lu T; Cui C; Li Z
Mol Carcinog; 2024 Jan; 63(1):22-33. PubMed ID: 37877736
[TBL] [Abstract] [Full Text] [Related]
11. Cytotoxic Imidazolyl-Mesalazine Ester-Based Ru(II) Complexes Reduce Expression of Stemness Genes and Induce Differentiation of Oral Squamous Cell Carcinoma.
Kumari P; Ghosh S; Acharya S; Mitra P; Roy S; Ghosh S; Maji M; Singh S; Mukherjee A
J Med Chem; 2023 Oct; 66(20):14061-14079. PubMed ID: 37831489
[TBL] [Abstract] [Full Text] [Related]
12. Molecular characterisation of tumours of the lacrimal apparatus.
Vibert R; Cyrta J; Girard E; Vacher S; Dupain C; Antonio S; Wong J; Baulande S; De Sousa JMF; Vincent-Salomon A; Masliah-Planchon J; Girard N; Le Tourneau C; Kamal M; Bièche I
Histopathology; 2023 Dec; 83(6):925-935. PubMed ID: 37706251
[TBL] [Abstract] [Full Text] [Related]
13. Genetic characteristics of advanced oral tongue squamous cell carcinoma in young patients.
Kim S; Lee C; Kim H; Yoon SO
Oral Oncol; 2023 Sep; 144():106466. PubMed ID: 37393663
[TBL] [Abstract] [Full Text] [Related]
14. CDK12 alterations and ARID1A mutations are predictors of poor prognosis and therapeutic targets in high-grade salivary gland carcinoma: analysis of the National Genomic Profiling Database.
Kobayashi K; Saito Y; Kage H; Fukuoka O; Yamamura K; Mukai T; Oda K; Yamasoba T
Jpn J Clin Oncol; 2023 Aug; 53(9):798-807. PubMed ID: 37357968
[TBL] [Abstract] [Full Text] [Related]
15. PLS3 promotes papillary thyroid carcinoma progression by activating the Notch signaling pathway.
Wang D; Liu J; Chen Y; Jia L; Zhao K; He X
Environ Toxicol; 2024 Feb; 39(2):539-550. PubMed ID: 37347555
[TBL] [Abstract] [Full Text] [Related]
16. Data mining on identifying diagnosis and prognosis biomarkers in head and neck squamous carcinoma.
Ju G; Yao Z; Zhao Y; Zhao X; Liu F
Sci Rep; 2023 Jun; 13(1):10020. PubMed ID: 37340028
[TBL] [Abstract] [Full Text] [Related]
17. Expression of Epsin3 and its interaction with Notch signalling in oral epithelial dysplasia and oral squamous cell carcinoma.
Ahmed H; Paterson I; Aziz SA; Cremona O; Robinson M; Carrozzo M; Valentine RA
J Oral Pathol Med; 2023 Sep; 52(8):710-717. PubMed ID: 37339783
[TBL] [Abstract] [Full Text] [Related]
18. Diabetes, metformin use, and survival in esophageal cancer: a population-based cohort study.
Wang QL; Santoni G; Lagergren J
JNCI Cancer Spectr; 2023 Jul; 7(4):. PubMed ID: 37314979
[TBL] [Abstract] [Full Text] [Related]
19. Key Genetic Determinants Driving Esophageal Squamous Cell Carcinoma Initiation and Immune Evasion.
Ko KP; Huang Y; Zhang S; Zou G; Kim B; Zhang J; Jun S; Martin C; Dunbar KJ; Efe G; Rustgi AK; Nakagawa H; Park JI
Gastroenterology; 2023 Sep; 165(3):613-628.e20. PubMed ID: 37257519
[TBL] [Abstract] [Full Text] [Related]
20. Comprehensive Genome profile testing in head and neck cancer.
Kuroki M; Iinuma R; Okuda H; Terazawa K; Shibata H; Mori KI; Ohashi T; Makiyama A; Futamura M; Miyazaki T; Horikawa Y; Ogawa T
Auris Nasus Larynx; 2023 Dec; 50(6):952-959. PubMed ID: 37164815
[TBL] [Abstract] [Full Text] [Related]
[Next]
